Microbot Medical Inc. (MBOT) Stock

Microbot Medical Inc. operates as a pioneering medical device company in the pre-clinical stage, specializing in the research, design, and development of robotic devices for endoluminal surgery. Focused on advancing minimally invasive surgical techniques, the company leverages its proprietary technologies such as ViRob, TipCAT, CardioSert, and Liberty. These innovations are tailored for various medical applications, including the development of a Self Cleaning Shunt for treating hydrocephalus and normal pressure hydrocephalus, as well as disposable robots for endovascular interventional procedures. With a robust pipeline, Microbot Medical continues to expand its portfolio of cutting-edge solutions.

Headquartered in Hingham, Massachusetts, Microbot Medical Inc. was established in 2010 and has since garnered recognition for its innovative approach to medical robotics. The company holds 42 issued or allowed patents globally, with an additional 23 patent applications pending, underscoring its commitment to technological advancement and intellectual property protection. Microbot Medical has also forged strategic collaborations, including a notable agreement with Stryker Corporation for joint technology development initiatives.

Driven by a vision to redefine surgical precision and patient care, Microbot Medical Inc. remains at the forefront of medical robotics innovation. Through strategic partnerships and ongoing research efforts, the company aims to introduce transformative medical solutions that enhance procedural efficiency and patient outcomes on a global scale.